Charles Schwab’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,406
| Closed | -$44K | – | 3555 |
|
|
2022
Q1 | $44K | Hold |
5,406
| – | – | ﹤0.01% | 3545 |
|
|
2021
Q4 | $44K | Hold |
5,406
| – | – | ﹤0.01% | 3522 |
|
|
2021
Q3 | $65K | Sell |
5,406
-35,123
| -87% | -$422K | ﹤0.01% | 3419 |
|
|
2021
Q2 | $629K | Sell |
40,529
-10,144
| -20% | -$157K | ﹤0.01% | 3090 |
|
|
2021
Q1 | $1.22M | Buy |
50,673
+2,662
| +6% | +$63.9K | ﹤0.01% | 2789 |
|
|
2020
Q4 | $1.42M | Buy |
48,011
+822
| +2% | +$24.3K | ﹤0.01% | 2682 |
|
|
2020
Q3 | $722K | Buy |
47,189
+13,709
| +41% | +$210K | ﹤0.01% | 2766 |
|
|
2020
Q2 | $837K | Buy |
33,480
+2,991
| +10% | +$74.8K | ﹤0.01% | 2676 |
|
|
2020
Q1 | $622K | Buy |
30,489
+435
| +1% | +$8.87K | ﹤0.01% | 2639 |
|
|
2019
Q4 | $929K | Buy |
30,054
+2,697
| +10% | +$83.4K | ﹤0.01% | 2620 |
|
|
2019
Q3 | $914K | Sell |
27,357
-3,968
| -13% | -$133K | ﹤0.01% | 2601 |
|
|
2019
Q2 | $1M | Buy |
31,325
+5,950
| +23% | +$191K | ﹤0.01% | 2571 |
|
|
2019
Q1 | $729K | Sell |
25,375
-1,965
| -7% | -$56.5K | ﹤0.01% | 2644 |
|
|
2018
Q4 | $1.1M | Sell |
27,340
-331
| -1% | -$13.3K | ﹤0.01% | 2511 |
|
|
2018
Q3 | $1.29M | Buy |
27,671
+17,275
| +166% | +$807K | ﹤0.01% | 2542 |
|
|
2018
Q2 | $856K | Buy |
+10,396
| New | +$856K | ﹤0.01% | 2627 |
|